Abstract: OBJECTIVES: Crohn’s disease (CD) requires life-long disease management. The study objective was to investigate the burden of CD and unmet medical need in patients who receive biologic therapy in Greece. METHODS: Between October 2023 and January 2024, adult...
Abstract:OBJECTIVES: To estimate the cost-effectiveness of epcoritamab compared to available treatment alternatives for treating relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) after at least two lines of systemic therapy in Greece. METHODS: A...
Abstract: OBJECTIVES: To estimate the budget impact from the introduction of Ivosidenib for the treatment of patients with locally advanced or metastatic cholangiocarcinoma (CCA) with an IDH1 R132 mutation who were previously treated by at least one prior line of...
Abstract: OBJECTIVES: To investigate the budgetary impact of adopting epcoritamab for the recently indicated treatment of relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) after at least two lines of systemic therapy in Greece. METHODS: A budget...
Abstract: OBJECTIVES: A recently published observational study, for the management of non-valvular atrial fibrillation (NVAF), suggests that switching from apixaban to rivaroxaban may be associated with higher risk for unfavorable outcomes. There is a lack of evidence...